TKM 080301 for Primary or Secondary Liver Cancer

NCT01437007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1

Enrollment

NIH

Sponsor class

Conditions

Colorectal Cancer With Hepatic Metastases
Pancreas Cancer With Hepatic Metastase
Gastric Cancer With Hepatic Metastase
Breast Cancer With Hepatic Metastase
Ovarian Cancer With Hepatic Metastase

Interventions

DRUG: TKM-080301

Sponsor

National Cancer Institute (NCI)